Jasper Therapeutics Ownership | Who Owns Jasper Therapeutics?

Jasper Therapeutics Ownership Summary

Jasper Therapeutics is owned by 13.27% institutional investors, 1.19% insiders, and 85.54% retail investors. Velan capital investment management lp is the largest institutional shareholder, holding 13.92% of JSPR shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.85% of its assets in Jasper Therapeutics shares.

JSPR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Jasper Therapeutics	13.27%	1.19%	85.54%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Velan capital investment management lp	2.67M	13.92%	$2.34M
Millennium management	1.62M	8.44%	$1.42M
Vanguard group	1.33M	8.00%	$2.43M
Acorn capital advisors	1.41M	7.36%	$1.24M
Kingdon capital management	1.35M	7.05%	$1.18M
Morgan stanley	1.33M	6.96%	$1.17M
Qiming u.s. ventures management	928.96K	6.18%	$2.21M
Rock springs capital management lp	1.10M	5.74%	$964.46K
Carlyle group	1.07M	5.56%	$934.20K
Boothbay fund management	582.75K	3.04%	$510.61K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Qiming u.s. ventures management	928.96K	3.97%	$2.21M
Lion point capital, lp	465.00K	2.44%	$407.43K
Velan capital investment management lp	2.67M	1.46%	$2.34M
Acorn capital advisors	1.41M	0.35%	$1.24M
Kingdon capital management	1.35M	0.13%	$1.18M
Knott david m jr	160.79K	0.08%	$140.88K
Verdad advisers, lp	73.97K	0.07%	$64.81K
Rock springs capital management lp	1.10M	0.06%	$964.46K
Diker management	35.00K	0.03%	$30.67K
Quarry lp	131.53K	0.02%	$115.25K

Top Buyers

Holder	Shares	% Assets	Change
Kingdon capital management	1.35M	0.13%	1.35M
Millennium management	1.62M	0.00%	543.75K
Armistice capital	348.00K	0.01%	348.00K
Vanguard group	1.33M	-	293.67K
Jacobs levy equity management	322.27K	0.00%	267.47K

Top Sellers

Holder	Shares	% Assets	Change
Goldman sachs group	-	-	-1.75M
Woodline partners lp	-	-	-1.04M
Propel bio management	-	-	-1.03M
T. rowe price investment management	-	-	-964.75K
Braidwell lp	-	-	-714.66K

New Positions

Holder	Shares	% Assets	Change	Value
Armistice capital	348.00K	0.01%	348.00K	$828.24K
Vanguard fiduciary trust	149.94K	-	149.94K	$131.35K
Verdad advisers, lp	73.97K	0.07%	73.97K	$64.81K
Marshall wace, llp	45.66K	-	45.66K	$40.18K
Nine masts capital	44.16K	0.01%	44.16K	$38.70K

Sold Out

Holder	Change
Barclays	-1.00
Rossby financial, lcc	-2.00
Sterling capital management	-12.00
Wolff wiese magana	-15.00
Coldstream capital management	-38.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	13	-77.59%	2,543,150	-86.77%	13	0.10%	6	-81.82%	4	-63.64%
Dec 31, 2025	7	-89.06%	1,540,911	-92.35%	9	0.05%	3	-90.91%	2	-88.89%
Sep 30, 2025	12	-80.33%	3,749,017	-66.07%	24	0.46%	6	-81.82%	3	-78.57%
Jun 30, 2025	65	-2.99%	12,501,153	8.39%	83	1.33%	35	16.67%	15	-34.78%
Mar 31, 2025	70	-24.73%	13,034,411	-16.69%	89	0.78%	32	-38.46%	23	35.29%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Polar Capital Healthcare Opports Inc	581.54K	3.85%	-
Vanguard Total Stock Mkt Idx Inv	833.39K	2.98%	-
Franklin Biotechnology Discv A(acc)USD	339.25K	2.26%	-
iShares Russell 2000 ETF	285.63K	1.90%	-
HBM Healthcare Investments AG Ord	250.00K	1.67%	-
T. Rowe Price U.S. SC Value Eq Tr-Z	245.81K	1.64%	217.41K
T. Rowe Price Small-Cap Value	394.02K	1.41%	-154.27K
Fidelity Select Health Care	208.04K	1.39%	208.04K
T. Rowe Price U.S. SC Value Eq Tr-D	385.52K	1.38%	520.00
Franklin Biotechnology Discovery A	195.44K	1.30%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 22, 2025	WIGGANS THOMAS G	-	Buy	$119.72K
Sep 22, 2025	WIGGANS THOMAS G	-	Buy	$99.63K
Sep 22, 2025	Lucas Svetlana	-	Buy	$48.60K
Sep 22, 2025	Lucas Svetlana	-	Buy	$58.40K
Sep 22, 2025	MARTELL RON	President and CEO	Buy	$99.63K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	8	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	1
2024 Q3	-	1

JSPR Ownership FAQ

Who Owns Jasper Therapeutics?

Jasper Therapeutics shareholders are primarily institutional investors at 13.27%, followed by 1.19% insiders and 85.54% retail investors. The average institutional ownership in Jasper Therapeutics's industry, Biotech Stocks , is 35.75%, which Jasper Therapeutics falls below.

Who owns the most shares of Jasper Therapeutics?

Jasper Therapeutics’s largest shareholders are Velan capital investment management lp (2.67M shares, 13.92%), Millennium management (1.62M shares, 8.44%), and Vanguard group (1.33M shares, 8.00%). Together, they hold 30.36% of Jasper Therapeutics’s total shares outstanding.

Does Blackrock own Jasper Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Jasper Therapeutics.

Who is Jasper Therapeutics’s biggest shareholder by percentage of total assets invested?

Qiming u.s. ventures management is Jasper Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.97% of its assets in 928.96K Jasper Therapeutics shares, valued at 2.21M$.

Who is the top mutual fund holder of Jasper Therapeutics shares?

Polar Capital Healthcare Opports Inc is the top mutual fund holder of Jasper Therapeutics shares, with 3.85% of its total shares outstanding invested in 581.54K Jasper Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools